Like insulin, the influence of IGF-1 is also diminished in the IUGR fetus, as circulating IGF-1 concentrations and skeletal muscle signaling components are reduced (Thorn et al., 2009; Rozance et al., 2018). The gene discussed is IGF1; the disease is fetal growth restriction.